6-month double-blind study. Int. J. Clin. Pharmacol. Res. 2001; 21: 43‒57.
269.Castano G., Mas R., Fernandez J.C. et al.
Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia. Drugs R.D. 2002; 3: 159–172.
270.Castano G., Mas R., Fernandez J.C. et al.
Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk. J. Gerontol. 2001; 56A: M186–M192.
271.Castano G., Mas R., Fernandez L. et al.
Effects of policosanol and lovastatin in patients with intermittent claudication: a double-blind comparative pilot study. Angiology. 2003; 54: 25–38.
272.Castano G., Mas R., Fernandez L. et al.
Effects of policosanol on postmenopausal women with type II hypercholesterolemia. Gynecol. Endocrinol. 2000; 14: 187–195.
273.Castano G., Mas R., Gamez R. et al. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study. Angiology. 2004; 55: 361–371.
274.Castano G., Mas R., Nodarse M. et al. Oneyear study of the efficacy and safety of policosanol (5 mg twice daily) in the treatment of type II hypercholesterolemia. Curr. Ther. Res. Clin. Exp. 1995;
56:296–304.
275.Castano G., Mas R., Roca J. et al. A dou- ble-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication. Angiology. 1999; 50: 123–130.
276.Castano G., Tula L., Canetti M. et al. Effects of policosanol in hypertensive patients with type II hypercholesterolemia. Curr. Ther. Res. Clin. Exp. 1996; 57: 691–699.
277.Castell L.M., Poortmans J.R., Newsholme E.A.
Does glutamine have a role in reducing infections in athletes? Eur. J. Appl. Physiol. 1996; 73(5): 488–490.
278.Castro-Barquero S., Lamuela-Raventós R.M., Doménech M., Estruch R. Relationship between Med-
iterranean Dietary Polyphenol Intake and Obesity. Nutrients. 2018; 10(10). pii: E1523. doi: 10.3390/ nu10101523.
279.Catenacci V., Pan Z., Ostendorf D. et al.
A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. Obesity (Silver Spring). 2016; 24(9): 1874–1883. doi: 10.1002/oby.21581.
280.Cavun S., Goktalay G., Millington R. Gly- cyl-Glutamine, an endogenous β-Endorphin-derived peptide, inhibits Morphine-induced conditioned place preference, tolerance, dependence, and withdrawal. J. Pharmacol. Experim. Ther. 2005; 315(2): 949–958.
281.Cederholm T., Barazzoni R., Austin P. et al.
ESPEN guidelines on definitions and terminology of clinical nutrition. Clin. Nutr. 2017; 36(1): 49–64. doi: 10.1016/j.clnu.2016.09.004.
282.Ceglia L., Niramitmahapanya S., da Silva M.M. et al. A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J. Clin. Endocrinol. Metab. 2013; 98(12): E1927–1935. doi: 10.1210/jc.2013–2820.
283.Cerdá B., Pérez M., Pérez-Santiago J.D. et al. Gut microbiota modification: another piece in the puzzle of the benefits of physical exercise in health? Front Phys. 2016; 7: 51. doi: 10.3389/fphys.2016.00051.
284.Cermak N.M., Gibala M.J., van Loon L.J.
Nitrate supplementation’s improvement of 10-km timetrial performance in trained cyclists. Int. J. Sport Nutr. Exerc. Metab. 2012a; 22(1): 64–71.
285.Cermak N.M., Res P., Stinkens R. et al. No improvement in endurance performance after a single dose of beetroot juice. Int. J. Sport Nutr. Exerc. Metab. 2012b; 22(6): 470–478.
286.Chang C-K., Borer K., Lin P-J. Low-Car- bohydrate-High-Fat Diet: Can it Help Exercise Performance? J. Human Kinetics. 2017; 56: 81–92. doi: 10.1515/hukin-2017–0025.
287.Chang J., Kashyap S. The protein-sparing modified fast for obese patients with type 2 diabe-